RU2015150099A3 - - Google Patents

Download PDF

Info

Publication number
RU2015150099A3
RU2015150099A3 RU2015150099A RU2015150099A RU2015150099A3 RU 2015150099 A3 RU2015150099 A3 RU 2015150099A3 RU 2015150099 A RU2015150099 A RU 2015150099A RU 2015150099 A RU2015150099 A RU 2015150099A RU 2015150099 A3 RU2015150099 A3 RU 2015150099A3
Authority
RU
Russia
Application number
RU2015150099A
Other versions
RU2015150099A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2015150099A publication Critical patent/RU2015150099A/ru
Publication of RU2015150099A3 publication Critical patent/RU2015150099A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2242Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
RU2015150099A 2009-07-23 2016-01-22 Композиция кожного препарата для наружного применения RU2015150099A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2009-172589 2009-07-23
JP2009172589 2009-07-23
JP2010-134600 2010-06-11
JP2010134600 2010-06-11

Publications (2)

Publication Number Publication Date
RU2015150099A RU2015150099A (ru) 2017-07-27
RU2015150099A3 true RU2015150099A3 (ru) 2019-07-17

Family

ID=43499204

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2012103653/15A RU2572694C2 (ru) 2009-07-23 2010-07-23 Композиция кожного препарата для наружного применения
RU2015150099A RU2015150099A (ru) 2009-07-23 2016-01-22 Композиция кожного препарата для наружного применения

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RU2012103653/15A RU2572694C2 (ru) 2009-07-23 2010-07-23 Композиция кожного препарата для наружного применения

Country Status (15)

Country Link
US (4) US20120208756A1 (ru)
EP (1) EP2457581B1 (ru)
JP (5) JP4834190B2 (ru)
KR (2) KR101533695B1 (ru)
CN (4) CN104189893B (ru)
AU (1) AU2010274293B9 (ru)
BR (1) BR112012001491B1 (ru)
CA (1) CA2768810C (ru)
DK (1) DK2457581T3 (ru)
ES (1) ES2456502T3 (ru)
HK (1) HK1171193A1 (ru)
MX (1) MX2012001024A (ru)
NZ (1) NZ597797A (ru)
RU (2) RU2572694C2 (ru)
WO (1) WO2011010732A1 (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ597797A (en) 2009-07-23 2013-11-29 Igisu Co Ltd Skin external-preparation composition
CA2825382C (en) 2011-01-21 2020-07-28 Kyoko Endo An agent comprising a natriuretic peptide for the treatment of alopecia
ES2488740B1 (es) * 2012-10-10 2015-06-11 J. Álvaro GALIANO RAMOS Formulación cosmética y dermatologica para el alivio del prurito
CN104367925A (zh) * 2014-11-07 2015-02-25 济南高达信息技术有限公司 一种治疗红皮病的中药洗剂及其制备方法
KR20180010267A (ko) * 2015-05-29 2018-01-30 가부시키가이샤 이기스 환상 펩티드 및 그 환상 펩티드를 포함한 의약, 외용제 및 화장료
EP3310392A4 (en) * 2015-06-19 2019-03-27 Global Health Solutions, LLC VASELINE ADMINISTRATION SYSTEMS FOR ACTIVE INGREDIENTS
WO2017022728A1 (ja) * 2015-07-31 2017-02-09 株式会社イギス Cnp環状ペプチド並びに該環状ペプチドを含む医薬品、外用剤および化粧料
CN105617360B (zh) * 2015-12-04 2018-12-21 中国农业大学 C-型钠肽在制备外用避孕药和精子功能检测试剂中的应用
CN109310647A (zh) * 2016-05-05 2019-02-05 阿奎斯蒂弗医疗股份有限公司 具有增强渗透的药物组合物
WO2018056907A1 (en) * 2016-09-21 2018-03-29 Agency For Science, Technology And Research Methods and compositions for inhibiting skin inflammation and determining cancer susceptibility
JP7125862B2 (ja) * 2018-05-29 2022-08-25 小林製薬株式会社 外用組成物
JP2019214520A (ja) * 2018-06-12 2019-12-19 花王株式会社 角層剥離改善剤
CN110302194B (zh) * 2019-07-23 2023-01-31 广州市皮肤病防治所(广州市性病防治监测中心) 一种具有抗炎和皮肤屏障保护作用的桉叶素联合糖皮质激素的复方制剂
US11419917B2 (en) 2020-04-07 2022-08-23 Drora Shevy Treatment for SARS-CoV-2 and other coronaviruses
JP7466939B2 (ja) 2022-08-31 2024-04-15 東洋ビューティ株式会社 O/d相組成物及び水中油型乳化組成物

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
JP2809533B2 (ja) * 1991-01-31 1998-10-08 壽之 松尾 Cnp類似体ペプチド
JPH05207891A (ja) 1991-03-08 1993-08-20 Shionogi & Co Ltd 脳性ナトリウム利尿ペプチドの製造方法
WO1994020534A1 (en) 1993-03-03 1994-09-15 Mayo Foundation For Medical Education And Research Vasonatrin peptide and analogs thereof
US6028055A (en) 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP
US5965533A (en) 1997-05-23 1999-10-12 Baxter International Inc. Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions
JP3799465B2 (ja) 1998-09-28 2006-07-19 参天製薬株式会社 ナトリウム利尿ペプチドを有効成分とする涙液分泌促進または角結膜障害治療用点眼剤
WO2000018422A1 (fr) 1998-09-28 2000-04-06 Santen Pharmaceutical Co., Ltd. Promoteurs de secretion lacrymale ou gouttes ophtalmologiques contenant des peptides natriuretiques comme principes actifs pour traiter la keratoconjonctivite
US6407211B1 (en) * 1999-12-17 2002-06-18 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides
IL142118A0 (en) 2001-03-20 2002-03-10 Prochon Biotech Ltd Method and composition for treatment of skeletal dysplasias
JP3676707B2 (ja) * 2001-07-18 2005-07-27 三菱電機株式会社 車両用交流発電機の固定子およびその製造方法
AU2003268531A1 (en) 2002-09-06 2004-03-29 University Of South Florida Materials and methods for treatment of allergic diseases
US20050271596A1 (en) 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US7648962B2 (en) * 2002-11-26 2010-01-19 Biocon Limited Natriuretic compounds, conjugates, and uses thereof
AU2003297583B2 (en) 2002-11-26 2010-01-14 Biocon, Ltd Modified naturetic compounds, conjugates, and uses thereof
US20040161435A1 (en) * 2003-02-14 2004-08-19 Gupta Shyam K. Skin Firming Anti-Aging Cosmetic Mask Compositions
EP1637162A4 (en) 2003-06-13 2009-07-15 Asubio Pharma Co Ltd MEDICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF IMMUNOLOGICAL ILLNESSES TH1 TYPE
ATE485303T1 (de) 2003-06-20 2010-11-15 Mayo Foundation Isoformen von gehirn-natriuretischem peptid
JP2007525213A (ja) 2004-01-27 2007-09-06 コンピュゲン ユーエスエイ,インク. 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
AU2005207886A1 (en) 2004-01-27 2005-08-11 Compugen Usa, Inc. Novel brain natriuretic peptide variants and methods of use thereof
EP3446711A1 (en) 2004-03-31 2019-02-27 Kazuwa Nakao Composition for increasing body height
EP1759710B1 (en) * 2004-03-31 2014-05-07 Kazuwa Nakao Remedy or preventive for arthritis
WO2006020841A2 (en) * 2004-08-11 2006-02-23 Alza Corporation Apparatus and method for transdermal delivery of natriuretic peptides
EP1810716A1 (de) * 2005-12-23 2007-07-25 Deutsches Zentrum für Luft- und Raumfahrt e.V. Verfahren zur Bräunung der Haut
DE102004048576A1 (de) * 2004-10-04 2006-04-13 Deutsches Zentrum für Luft- und Raumfahrt e.V. Methode zur Bräunung der Haut
US8324162B2 (en) 2006-08-08 2012-12-04 Mayo Foundation For Medical Education And Research Diuretic and natriuretic polypeptides lacking the blood pressure lowering property
WO2008032450A1 (fr) 2006-09-15 2008-03-20 Kyoto University Agent prophylactique et/ou thérapeutique pour une stéatose hépatique
WO2008082524A1 (en) 2006-12-19 2008-07-10 National Stem Cell Inc. Embryonic germ cell secreted product derived topical compositions and methods of use thereof
JP5010913B2 (ja) * 2006-12-31 2012-08-29 寿子 小出 心房利尿ホルモンファミリー分子を活性物質として含有する組織再生製剤また該製剤をもちいる組織再生方法、および心房利尿ホルモンファミリー分子を活性物質として含有する発毛、増毛、育毛剤および皮膚組織修復改善剤また該製剤を用いる発毛、増毛、育毛促進方法および皮膚組織修復改善方法
JP2010168283A (ja) 2007-04-24 2010-08-05 Yamaguchi Univ ナトリウム利尿ペプチドを有効成分とする肝硬変・前癌病変の抑制剤
WO2008140125A1 (ja) 2007-05-10 2008-11-20 National University Corporation Nagoya University 腹膜線維化抑制用医薬組成物
WO2009033807A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43
EP2187921A2 (en) 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Use of gonadorelin as a therapeutic agent
EP2217620A2 (en) * 2007-11-21 2010-08-18 BioMarin Pharmaceutical Inc. Variants of c-type natriuretic peptide
US8741842B2 (en) 2008-07-02 2014-06-03 Mayo Foundation For Medical Education And Research Chimeric natriuretic polypeptides with unique pharmacologic profiles
US8642550B2 (en) * 2008-10-24 2014-02-04 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides without hypotensive inducing capability
US8150603B2 (en) 2008-11-26 2012-04-03 Caterpillar Inc. Engine control system having fuel-based timing
WO2010078325A2 (en) 2008-12-29 2010-07-08 Mayo Foundation For Medical Education And Research Natriuretic polypeptides for reducing or preventing restenosis
KR102033680B1 (ko) * 2009-05-20 2019-10-18 바이오마린 파머수티컬 인크. 씨형 나트륨이뇨 펩티드의 변이체
NZ597797A (en) 2009-07-23 2013-11-29 Igisu Co Ltd Skin external-preparation composition
JP2011024973A (ja) * 2009-07-24 2011-02-10 Mitsumasa Maeda 電子ペーパー付き便蓋
WO2011024973A1 (ja) 2009-08-27 2011-03-03 株式会社 イギス 鼻炎治療剤
ITPG20090061A1 (it) 2009-11-27 2011-05-28 Andrea Marcantonini Impianto mobile per la produzione di calcestruzzo
CA2825382C (en) 2011-01-21 2020-07-28 Kyoko Endo An agent comprising a natriuretic peptide for the treatment of alopecia

Also Published As

Publication number Publication date
KR101226165B1 (ko) 2013-01-24
JPWO2011010732A1 (ja) 2013-01-07
KR20120130273A (ko) 2012-11-29
JP2017061556A (ja) 2017-03-30
WO2011010732A1 (ja) 2011-01-27
RU2572694C2 (ru) 2016-01-20
KR20120049169A (ko) 2012-05-16
CA2768810A1 (en) 2011-01-27
JP2012017316A (ja) 2012-01-26
CN102470163B (zh) 2016-06-15
AU2010274293B8 (en) 2013-07-04
JP2016006058A (ja) 2016-01-14
US20140072520A1 (en) 2014-03-13
ES2456502T3 (es) 2014-04-22
CN104189893A (zh) 2014-12-10
BR112012001491B1 (pt) 2022-03-15
JP6337071B2 (ja) 2018-06-06
EP2457581A4 (en) 2012-12-12
AU2010274293B9 (en) 2013-08-29
AU2010274293B2 (en) 2013-06-06
CN110339346A (zh) 2019-10-18
US9358269B2 (en) 2016-06-07
JP4834190B2 (ja) 2011-12-14
DK2457581T3 (da) 2014-03-31
CN104189893B (zh) 2018-10-23
RU2012103653A (ru) 2013-08-27
NZ597797A (en) 2013-11-29
JP6055518B2 (ja) 2016-12-27
CN110339346B (zh) 2023-06-27
US20180099028A1 (en) 2018-04-12
CA2768810C (en) 2014-05-20
MX2012001024A (es) 2012-04-11
KR101533695B1 (ko) 2015-07-06
CN102470163A (zh) 2012-05-23
US20160250293A1 (en) 2016-09-01
CN105999230A (zh) 2016-10-12
EP2457581A1 (en) 2012-05-30
CN105999230B (zh) 2022-06-24
US10946072B2 (en) 2021-03-16
HK1171193A1 (en) 2013-03-22
JP5778440B2 (ja) 2015-09-16
EP2457581B1 (en) 2014-01-08
JP2018135381A (ja) 2018-08-30
RU2015150099A (ru) 2017-07-27
US9968654B2 (en) 2018-05-15
AU2010274293A1 (en) 2012-02-23
BR112012001491A2 (pt) 2020-01-28
US20120208756A1 (en) 2012-08-16

Similar Documents

Publication Publication Date Title
BR112012008195A2 (ru)
BR112012000607A2 (ru)
BR112012003080A2 (ru)
BR112012000665A2 (ru)
BR112012003853A2 (ru)
BR112012009797A2 (ru)
BR112012009446A2 (ru)
BR112012009703A2 (ru)
BR112012010357A2 (ru)
BR112012007656A2 (ru)
BR112012002627A2 (ru)
BR112012001263A2 (ru)
RU2015150099A3 (ru)
BR112012000159A2 (ru)
BRPI1004942A2 (ru)
BR112012007654A2 (ru)
BR112012007672A2 (ru)
BR112012005951A2 (ru)
BR112012000255A2 (ru)
BR112012000156A2 (ru)
BR112012009404A2 (ru)
BR112012007671A2 (ru)
BR112012000689A2 (ru)
BRPI0925022A2 (ru)
BR112012003654A2 (ru)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20191025